XML 65 R50.htm IDEA: XBRL DOCUMENT v3.25.0.1
SUPPLEMENTAL FINANCIAL INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash and Cash Equivalents
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.
As of
December 31, 2024December 31, 2023
Cash and cash equivalents
$2,874 $2,494 
Short-term restricted cash16 10 
Total Cash, cash equivalents, and restricted cash as presented in the Consolidated Statements of Financial Position
2,889 2,504 
Long-term restricted cash(1)
3 2 
Total Cash, cash equivalents, and restricted cash as presented in the Consolidated and Combined Statements of Cash Flows
$2,893 $2,506 
(1) Long-term restricted cash is recognized within All other non-current assets in the Consolidated Statements of Financial Position.
Schedule of Restricted Cash and Cash Equivalents
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.
As of
December 31, 2024December 31, 2023
Cash and cash equivalents
$2,874 $2,494 
Short-term restricted cash16 10 
Total Cash, cash equivalents, and restricted cash as presented in the Consolidated Statements of Financial Position
2,889 2,504 
Long-term restricted cash(1)
3 2 
Total Cash, cash equivalents, and restricted cash as presented in the Consolidated and Combined Statements of Cash Flows
$2,893 $2,506 
(1) Long-term restricted cash is recognized within All other non-current assets in the Consolidated Statements of Financial Position.
Schedule of Inventory
INVENTORIES.
As of
December 31, 2024December 31, 2023
Raw materials$921 $961 
Work in process92 91 
Finished goods926 908 
Inventories
$1,939 $1,960 
Summary of Property, Plant and Equipment
PROPERTY, PLANT, AND EQUIPMENT – NET.
As of
December 31, 2024December 31, 2023
Land and improvements
$66 $70 
Buildings, structures, and related equipment
1,943 1,956 
Machinery and equipment
2,705 2,617 
Leasehold improvements and manufacturing plants under construction
553 565 
Total property, plant, and equipment, at original cost
5,267 5,208 
Accumulated depreciation
(3,080)(3,064)
Right-of-use operating lease assets, net of amortization(1)
364 356 
Property, plant, and equipment – net
$2,550 $2,500 
(1) See Note 7, “Leases” for further information.
Schedule of Other Current Assets
All Other Current and Non-Current Assets
As of
December 31, 2024December 31, 2023
Prepaid expenses and deferred costs
$188 $147 
Financing receivables – net
90 97 
Derivative instruments
123 84 
Tax receivables
115 53 
Other
13 8 
All other current assets
$529 $389 
Prepaid pension asset
$657 $716 
Equity method and other investments
373 357 
Financing receivables – net
183 178 
Long-term receivables – net
142 124 
Inventories
139 147 
Contract and other deferred assets
208 168 
Other(1)
248 191 
All other non-current assets
$1,950 $1,881 
(1) Non-current Other primarily consists of indemnity assets associated with separation agreements with GE, capitalized costs associated with cloud computing arrangements, tax receivables, and derivative instruments.
Schedule of Other Noncurrent Assets
All Other Current and Non-Current Assets
As of
December 31, 2024December 31, 2023
Prepaid expenses and deferred costs
$188 $147 
Financing receivables – net
90 97 
Derivative instruments
123 84 
Tax receivables
115 53 
Other
13 8 
All other current assets
$529 $389 
Prepaid pension asset
$657 $716 
Equity method and other investments
373 357 
Financing receivables – net
183 178 
Long-term receivables – net
142 124 
Inventories
139 147 
Contract and other deferred assets
208 168 
Other(1)
248 191 
All other non-current assets
$1,950 $1,881 
(1) Non-current Other primarily consists of indemnity assets associated with separation agreements with GE, capitalized costs associated with cloud computing arrangements, tax receivables, and derivative instruments.
Schedule of Other Current Liabilities
All Other Current and Non-Current Liabilities
As of
December 31, 2024December 31, 2023
Sales allowances and related liabilities
$242 $228 
Income and indirect tax liabilities including uncertain tax positions
279 260 
Product warranties
168 192 
Accrued freight and utilities
163 132 
Operating lease liabilities
115 110 
Derivative instruments(1)
90 128 
Interest payable on borrowings
92 87 
Environmental and asset retirement obligations
17 21 
Other(2)
379 335 
All other current liabilities
$1,545 $1,493 
Contract liabilities
$686 $705 
Operating lease liabilities
270 273 
Environmental and asset retirement obligations
291 265 
Income and indirect tax liabilities including uncertain tax positions
237 208 
Derivative instruments
64 136 
Finance lease obligations
40 38 
Sales allowances and related liabilities
23 27 
Other(3)
184 225 
All other non-current liabilities
$1,796 $1,877 
(1) Derivative instruments include the related accrued interest. Refer to Note 13, “Financial Instruments and Fair Value Measurements” for further information.
(2) Current Other primarily consists of miscellaneous accrued costs, contingent consideration liabilities, and dividends payable to stockholders.
(3) Non-current Other primarily consists of miscellaneous accrued costs, indemnity liabilities associated with separation agreements with GE, and contingent consideration liabilities.
Schedule of Other Noncurrent Liabilities
All Other Current and Non-Current Liabilities
As of
December 31, 2024December 31, 2023
Sales allowances and related liabilities
$242 $228 
Income and indirect tax liabilities including uncertain tax positions
279 260 
Product warranties
168 192 
Accrued freight and utilities
163 132 
Operating lease liabilities
115 110 
Derivative instruments(1)
90 128 
Interest payable on borrowings
92 87 
Environmental and asset retirement obligations
17 21 
Other(2)
379 335 
All other current liabilities
$1,545 $1,493 
Contract liabilities
$686 $705 
Operating lease liabilities
270 273 
Environmental and asset retirement obligations
291 265 
Income and indirect tax liabilities including uncertain tax positions
237 208 
Derivative instruments
64 136 
Finance lease obligations
40 38 
Sales allowances and related liabilities
23 27 
Other(3)
184 225 
All other non-current liabilities
$1,796 $1,877 
(1) Derivative instruments include the related accrued interest. Refer to Note 13, “Financial Instruments and Fair Value Measurements” for further information.
(2) Current Other primarily consists of miscellaneous accrued costs, contingent consideration liabilities, and dividends payable to stockholders.
(3) Non-current Other primarily consists of miscellaneous accrued costs, indemnity liabilities associated with separation agreements with GE, and contingent consideration liabilities.
Schedule of Equity Method Investments
EQUITY METHOD INVESTMENTS.
Equity method investment balanceEquity method income (loss)
As of December 31Ownership Percentage20242023202420232022
Nihon Medi-Physics Co., Ltd(1)
50%$139 $150 $10 $10 $16 
Other24 20 (2)1 (3)
Total$163 $170 $8 $11 $13 
(1) In the fourth quarter of 2024, GE HealthCare announced an agreement to acquire the remaining ownership interest of NMP. See Note 8, “Acquisitions, Goodwill, and Other Intangible Assets” for more information.
Schedule of Supply Chain Finance Programs
A rollforward of our outstanding obligations confirmed and paid under the supply chain finance programs, which are included within Accounts Payable in the Consolidated Statements of Financial Position, is presented below.
For the year ended December 31
2024
Confirmed obligations outstanding at beginning of period
$365 
Invoices confirmed during the year
886 
Confirmed invoices paid during the year
(855)
Foreign exchange and other
(2)
Confirmed obligations outstanding at end of period
$394 
Schedule of Redeemable Noncontrolling Interest
Activity attributable to redeemable noncontrolling interests is presented below.
For the years ended December 31
202420232022
Balance at beginning of period$165 $230 $220 
Net income attributable to redeemable noncontrolling interests
50 41 47 
Redemption value adjustments(1)
— 183 — 
Distributions to and exercise of redeemable noncontrolling interests and other(2)
(28)(289)(37)
Balance at end of period $188 $165 $230 
(1) As of January 3, 2023, certain redeemable noncontrolling interests were probable of becoming redeemable due to the change of control that occurred upon consummation of the Spin-Off. As a result, these redeemable noncontrolling interests were remeasured to their current redemption value. The remeasurement was accounted for as a deemed preferred stock dividend of redeemable noncontrolling interest and recorded as an adjustment to Retained earnings in the Consolidated Statements of Financial Position.
(2) In the first quarter of 2023, the redeemable noncontrolling interest holder exercised its option redemption provision. The redemption amount of $211 million was paid in the second quarter of 2023.
Schedule of Other Income (Expense)
OTHER INCOME (EXPENSE) – NET.
For the years ended December 31
202420232022
Net financing income and investment income (loss)
$(1)$26 $(9)
Equity method income (loss)
8 11 13 
Change in fair value of assumed obligations
(32)(32)— 
Other items, net(1)
80 81 58 
Total other income (expense) – net
$55 $86 $62 
(1) Other items, net primarily consists of: change in tax indemnity, lease income, government grants, licensing and royalty income, and gains and losses related to derivatives for the year ended December 31, 2024; change in tax indemnity, lease income, licensing and royalty income, and gains and losses related to derivatives for the year ended December 31, 2023; and gains and losses related to derivatives and licensing and royalty income for the year ended December 31, 2022.